Nadia Garman

Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)

Pauline T. Lukey, Christopher Coello, Roger N. Gunn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 65 citations · Full text

Medicine, Nuclear Medicine, Radiology +14

Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants

Charlotte Maden, David Fairman, Michelle Chalker et al. · European Journal of Clinical Pharmacology · 2018 · 63 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +8

Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID

Heide A. Stirnadel-Farrant, Mahesh Kudari, Nadia Garman et al. · Orphanet Journal of Rare Diseases · 2018 · 41 citations · Full text

Medicine, Hematology, Translational Sciences +17

A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of¹⁸F-FB-A20FMDV2 for Imaging the Integrin α_vβ₆

Nicholas Keat, Julia Kenny, Keguan Chen et al. · Journal of Nuclear Medicine Technology · 2018 · 30 citations · Full text

Medicine, Nuclear Medicine, Radiology +16

Series: Pragmatic trials and real world evidence: Paper 7. Safety, quality and monitoring

Elaine Irving, Rutger van den Bor, Paco M J Welsing et al. · Journal of Clinical Epidemiology · 2017 · 28 citations · Full text

Pharmacy, Pharmacology, Evidence-based Practice +16